image
Inhibikase Therapeutics, Inc. IKT
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 1.68
-8.7 %
$ 125 M
Market Cap
-1.45
P/E
Price Target Average
286.90%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
--51.07%
Net Income Estimate
31.53%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Inhibikase Therapeutics, Inc.
image
Wall Street analysts predict an average 1-year price target for IKT of $6.5 , with forecasts ranging from a low of $5 to a high of $8 .
IKT Lowest Price Target Wall Street Target
5 USD 197.62%
IKT Average Price Target Wall Street Target
6.5 USD 286.90%
IKT Highest Price Target Wall Street Target
8 USD 376.19%
Price
Max Price Target
Min Price Target
Average Price Target
8877665544332211May '24May '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
REVENUE FORECAST

Revenue Forecast Chart IKT

image
$180.0m$180.0m$160.0m$160.0m$140.0m$140.0m$120.0m$120.0m$100.0m$100.0m$80.0m$80.0m$60.0m$60.0m$40.0m$40.0m$20.0m$20.0m$0.0$0.02021202120222022202320232024202420252025202620262027202720282028
EBIT FORECAST

EBIT Forecast Chart IKT

image
$0.0$0.0($10.0m)($10.0m)($20.0m)($20.0m)($30.0m)($30.0m)($40.0m)($40.0m)($50.0m)($50.0m)($60.0m)($60.0m)($70.0m)($70.0m)($80.0m)($80.0m)($90.0m)($90.0m)($100.0m)($100.0m)2021202120222022202320232024202420252025202620262027202720282028
NET INCOME FORECAST

Net Income Chart IKT

image
$10.0m$10.0m$0.0$0.0($10.0m)($10.0m)($20.0m)($20.0m)($30.0m)($30.0m)($40.0m)($40.0m)($50.0m)($50.0m)($60.0m)($60.0m)($70.0m)($70.0m)2021202120222022202320232024202420252025202620262027202720282028